- 2014
-
What's on? - 13.05.2014
Heavy mobile telephone use and brain tumours
Findings from the study of mobile telephone use and the development of brain tumours have been published in the journal Occupational & Environmental Medicine The effect of electromagnetic radio frequencies on humans remains controversial. Researchers from Inserm Unit 897, “Epidemiology and Biostatistics” (ISPED) in Bordeaux, have analysed the association between exposure to mobile telephone radio frequencies […]
-
Press releases - 13.05.2014
The pill crisis in France: towards a new contraceptive model?
By analysing the Fecond survey, conducted by Inserm and the French National Institute for Demographic Studies (INED) several months later, Nathalie Bajos, Mylène Rouzaud-Cornabas, Henri Panjo, Aline Bohet and Caroline Moreau examined the recent trends in contraceptive practices, and the contribution of media debate to these changes.
-
Press releases - 12.05.2014
Retired people continue to have cognitive impairment long after high occupational exposure to solvents
French researchers from Inserm Unit 1061, “Neuropsychiatry: Epidemiological and Clinical Research,” and their American colleagues at Harvard have just shown that retired people continued to be affected by their work with solvents in cases of high exposure.
-
Press releases - 09.05.2014
A new type of heredity described in Paramecia
A team from the Institut de biologie at the Ecole normale supérieure (CNRS/ENS/INSERM)(2) has described how in Paramecia, mating types are transmitted from generation to generation through an unexpected mechanism.
-
What's on? - 09.05.2014
Breakthrough: new letters in the alphabet of life
In an article published yesterday in the journal Nature, an American team led by Floyd Romesberg (Scripps Research Institute, La Jolla, California) explains how it succeeded in integrating two new DNA bases into the genetic code of a bacterium. Their breakthrough is that the bacterium retains these genetic modifications during replication. To comment this findings, contact […]
-
News in brief - 07.05.2014
Using “good cholesterol” as a therapeutic vector for treating the lungs
One of the major challenges for therapeutic science is to optimise the accurate distribution of drugs in the affected organs. Targeted delivery methods are needed to accomplish this. In a new study published in The American Journal of Respiratory Cell and Molecular Biology, Olivier Meilhac’s team (Inserm Unit 1148, the “Laboratory for Vascular Translational Science,” […]
-
Press releases - 30.04.2014
Metastases: Tumour Cell Dissemination
Carine Rossé, INSERM research fellow and Philippe Chavrier, Research Director at CNRS, working alongside Dr. Anne Vincent-Salomon, medical researcher at the Institut Curie, have recently discovered one of the mechanisms that allow triple negative breast cancer cells to exit the mammary gland.
-
What's on? - 30.04.2014
World Asthma Day
World Asthma Day will take place on 6 May next. This chronic inflammatory respiratory disease is caused by an abnormal reactivity to environmental substances known as “allergens,” since they are liable to provoke an allergic reaction or irritation of the respiratory tract (pollutants, mites, pollens, etc.). It is characterised by recurrent attacks during which the […]
-
What's on? - 23.04.2014
25 April 2014 – World Malaria Day
According to WHO, malaria in pregnant women (Pregnancy Associated Malaria) constitutes a major public health problem, involving substantial risks for the mother and foetus, and hence the newborn. The main consequences of infection with Plasmodium falciparum are a malaria-related pathology in the mother and low birth weight in the infant, an important factor in infant […]
-
Press releases - 22.04.2014
Discovery of two types of adrenal cancer
Adrenocortical carcinoma (also known as adrenal cortex cancer or ACC), is a generally aggressive tumour, with a mean survival rate of less than five years for those affected. Apart from metastasis, it exposes the patients to manifestations such as high blood pressure, diabetes, decreased potassium level, infections, etc. There is, however, some patient-dependent variation in tumour development. The team led by Prof. Bertherat at the Cochin Institute (Inserm – CNRS – Paris Descartes University) and the Expert Centre for Rare Adrenal Cancers at Cochin Hospital (AP-HP) has just published a molecular classification for this cancer in the journal Nature Genetics. The researchers identify many molecular abnormalities in these cancers that have not been well known until now, and thus reveal a new classification for these tumours.